Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 2Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Pituitary Neoplasms 1

Interventions

sintilimab 1oxycodone-acetaminophen 1bismuth tripotassium dicitrate 1Tetracycline 1Tacrolimus 1Tablets 1Ropivacaine 1Photochemotherapy 1Mycophenolic Acid 1Metronidazole 1Magnetic Resonance Spectroscopy 1Lacteol 1Infliximab 1Gastrointestinal Microbiome 1Fluorouracil 1Eye Enucleation 1Everolimus 1Esomeprazole 1Enoxaparin 1Drug Therapy 1Cryotherapy 1Cabergoline 1CT-P13 1Azathioprine 1Aspirin 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Enrolling by invitation × Cabergoline × Clear all
NCT07034859 2025-06-24

Cabergoline in the Management of Nonfunctioning Pituitary Adenoma

National Taiwan University Hospital

Phase 4 Enrolling by invitation
30 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡